Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers

scientific article published on 09 March 2016

Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.18632/ONCOTARGET.8014
P932PMC publication ID4991491
P698PubMed publication ID26980748

P50authorJames R. BradfordQ42552817
Nicola J CampQ87666063
P2093author name stringHenry Brown
Simon T Barry
Anne Marie Mazzola
Celina D'Cruz
Armelle Logie
Garry Beran
Joanna Boros
Mark Wappett
Oona Delpuech
Robert McEwen
P2860cites workThe CD44+/CD24- phenotype is enriched in basal-like breast tumorsQ21092906
Hallmarks of Cancer: The Next GenerationQ22252312
Cytoscape: a software environment for integrated models of biomolecular interaction networksQ24515682
Ensembl 2014Q24567767
NCBI GEO: archive for functional genomics data sets--updateQ24595691
Patient-derived tumour xenografts as models for oncology drug developmentQ24604068
Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic nicheQ24606366
Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiationQ24627354
Comprehensive molecular portraits of human breast tumoursQ24630844
RNA-Seq Differentiates Tumour and Host mRNA Expression Changes Induced by Treatment of Human Tumour Xenografts with the VEGFR Tyrosine Kinase Inhibitor CediranibQ27315803
Lysyl oxidase mediates hypoxic control of metastasisQ28271667
Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancerQ28275492
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2Q29547403
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityQ29547693
HTSeq--a Python framework to work with high-throughput sequencing dataQ29614489
Comment on: The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer.Q43171997
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancerQ46085608
E-Cadherin and EpCAM expression by NSCLC tumour cells associate with normal fibroblast activation through a pathway initiated by integrin αvβ6 and maintained through TGFβ signalling.Q54380363
Relation of a Hypoxia Metagene Derived from Head and Neck Cancer to Prognosis of Multiple CancersQ58211840
Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published databaseQ81336038
Purity for clarity: the need for purification of tumor cells in DNA microarray studiesQ81471249
Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patientsQ83978512
STAR: ultrafast universal RNA-seq alignerQ29615052
Supervised risk predictor of breast cancer based on intrinsic subtypesQ29617404
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapiesQ29617680
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating featuresQ29620020
Inferring tumour purity and stromal and immune cell admixture from expression dataQ30674996
Stromal gene expression predicts clinical outcome in breast cancerQ33330931
A flexible R package for nonnegative matrix factorizationQ33624159
EMT is the dominant program in human colon cancerQ33798739
Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization.Q34137672
Patient-derived xenograft models: an emerging platform for translational cancer researchQ34205518
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitorsQ34296476
Gene expression profiles of estrogen receptor-positive and estrogen receptor-negative breast cancers are detectable in histologically normal breast epitheliumQ34686883
β-Catenin and NF-κB co-activation triggered by TLR3 stimulation facilitates stem cell-like phenotypes in breast cancerQ34924186
Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics.Q34937584
ToppGene Suite for gene list enrichment analysis and candidate gene prioritizationQ34982758
Tumor engraftment in nude mice and enrichment in stroma- related gene pathways predict poor survival and resistance to gemcitabine in patients with pancreatic cancer.Q35534811
GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cellsQ35605895
Tumor intrinsic subtype is reflected in cancer-adjacent tissue.Q35624103
Characterization and clinical evaluation of CD10+ stroma cells in the breast cancer microenvironmentQ35655229
Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man?Q35906275
Xenome--a tool for classifying reads from xenograft samples.Q36022173
TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer.Q36142926
The molecular profile of luminal B breast cancerQ36196676
Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients.Q36245556
Gene expression changes in a tumor xenograft by a pyrrole-imidazole polyamideQ36342812
Molecular characterization of basal-like and non-basal-like triple-negative breast cancerQ36630430
Cancer stem cells and tumor transdifferentiation: implications for novel therapeutic strategiesQ36796375
Origin of the vasculature supporting growth of primary patient tumor xenograftsQ36863454
ANTXR1, a stem cell-enriched functional biomarker, connects collagen signaling to cancer stem-like cells and metastasis in breast cancer.Q37185320
Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signaturesQ37281532
Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes.Q37321751
The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancerQ37681755
Stromal contribution to the colorectal cancer transcriptome.Q38906913
Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotypeQ40012189
Dual regulation of macrophage migration inhibitory factor (MIF) expression in hypoxia by CREB and HIF-1.Q40253607
Identification of DEAD-box RNA helicase 6 (DDX6) as a cellular modulator of vascular endothelial growth factor expression under hypoxiaQ41832579
P4510describes a project that usesCytoscapeQ3699942
limmaQ112236343
DESeq2Q113018293
P433issue15
P407language of work or nameEnglishQ1860
P921main subjectpatientQ181600
transcriptomeQ252857
biomarkerQ864574
RNA sequencingQ2542347
xenograftQ64148587
P304page(s)20773-20787
P577publication date2016-03-09
P1433published inOncotargetQ1573155
P1476titleWhole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers
P478volume7

Reverse relations

cites work (P2860)
Q89047103An Empirical Approach Leveraging Tumorgrafts to Dissect the Tumor Microenvironment in Renal Cell Carcinoma Identifies Missing Link to Prognostic Inflammatory Factors
Q64922761Comprehensive functional profiling of long non-coding RNAs through a novel pan-cancer integration approach and modular analysis of their protein-coding gene association networks.
Q36148711Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment
Q33667686Current status and perspectives of patient-derived xenograft models in cancer research
Q37361062LncRNA mediated regulation of aging pathways in Drosophila melanogaster during dietary restriction
Q48159135Modeling phenotypes of malignant gliomas
Q64244399Mouse-Derived Isograft (MDI) In Vivo Tumor Models I. Spontaneous sMDI Models: Characterization and Cancer Therapeutic Approaches
Q92922108Primary Tumor Site Specificity is Preserved in Patient-Derived Tumor Xenograft Models
Q49319044Three-dimensional tumor model mimics stromal - breast cancer cells signaling.
Q93006559Zebrafish Avatars towards Personalized Medicine-A Comparative Review between Avatar Models

Search more.